The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the Netherlands
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.902
https://www.valueinhealthjournal.com/article/S1098-3015(14)02832-0/fulltext
Section Title :
Disease-Specific Studies
Section Order :
417
First Page :
A398
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02832-0&doi=10.1016/j.jval.2014.08.902